HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs.

Abstract
There is increasing interest in developing peptides for pharmacological intervention with pathophysiological functions of serine proteases. From phage-displayed peptide libraries, we previously isolated peptidylic inhibitors of urokinase-type plasminogen activator, a potential target for intervention with cancer invasion. The two peptides, upain-1 (CSWRGLENHRMC) and mupain-1 (CPAYSRYLDC), are competitive inhibitors of human and murine urokinase-type plasminogen activator, respectively. Both have an Arg as the P1 residue, inserting into the S1 pocket in the active site of the enzymes, but their specificity depends to a large extent on interactions outside the enzymes' active sites, so-called exosite interactions. Here we describe upain-2 (CSWRGLENHAAC) and the synthesis of a number of upain-2 and mupain-1 variants in which the P1 Arg was substituted with novel non-natural Arg analogs and achieved considerable improvement in the affinity of the peptides to their targets. Using chimeras of human and murine urokinase-type plasminogen activator as well as X-ray crystallography, we delineated the relative contribution of the P1 residue and exosite interactions to the affinity and specificity of the inhibitors for their target enzyme. The effect of inserting a particular non-natural amino acid into the P1 position is determined by the fact that changes in interactions of the P1 residue in the S1 pocket lead to changed exosite interactions and vice versa. These findings are of general interest when the affinities and specificities of serine protease inhibitors to be used for pharmacological intervention are considered and could pave the way for potential drug candidates for the treatment of cancer.
AuthorsMasood Hosseini, Longguang Jiang, Hans Peter Sørensen, Jan K Jensen, Anni Christensen, Sarah Fogh, Cai Yuan, Lisbeth M Andersen, Mingdong Huang, Peter A Andreasen, Knud J Jensen
JournalMolecular pharmacology (Mol Pharmacol) Vol. 80 Issue 4 Pg. 585-97 (Oct 2011) ISSN: 1521-0111 [Electronic] United States
PMID21719463 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptides
  • Peptides, Cyclic
  • Recombinant Proteins
  • Serine Proteinase Inhibitors
  • mupain-1
  • upain-1 peptide
  • Arginine
Topics
  • Amino Acid Sequence
  • Animals
  • Arginine (chemistry, genetics, metabolism)
  • Catalytic Domain (physiology)
  • Crystallography, X-Ray
  • HEK293 Cells
  • Humans
  • Mice
  • Molecular Sequence Data
  • Peptides (chemistry, genetics, metabolism)
  • Peptides, Cyclic (chemistry, genetics, metabolism)
  • Protein Binding (physiology)
  • Protein Structure, Tertiary
  • Recombinant Proteins (chemistry, genetics, metabolism)
  • Serine Proteinase Inhibitors (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: